ZNF700
gene geneOn this page
Also known as DKFZp434I1610
Summary
ZNF700 (zinc finger protein 700, HGNC:25292) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 700 (Q9H0M5). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 90592 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- MANE Select transcript:
NM_144566
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25292 |
| Approved symbol | ZNF700 |
| Name | zinc finger protein 700 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp434I1610 |
| Ensembl gene | ENSG00000196757 |
| Ensembl biotype | protein_coding |
| Entrez | 90592 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000254321, ENST00000482090, ENST00000622593
RefSeq mRNA: 2 — MANE Select: NM_144566
NM_001271848, NM_144566
CCDS: CCDS32915, CCDS74289
Canonical transcript exons
ENST00000254321 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001670858 | 11947181 | 11947307 |
| ENSE00001813248 | 11948276 | 11950763 |
| ENSE00002820298 | 11947514 | 11947574 |
| ENSE00003848096 | 11925107 | 11925273 |
Expression profiles
Bgee: expression breadth ubiquitous, 135 present calls, max score 87.83.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.6401 / max 106.2182, expressed in 1633 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173973 | 6.6819 | 1616 |
| 173972 | 1.6083 | 901 |
| 173974 | 0.9582 | 472 |
Top tissues by expression
135 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 87.83 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.74 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.53 | gold quality |
| metanephros cortex | UBERON:0010533 | 87.22 | gold quality |
| body of pancreas | UBERON:0001150 | 86.93 | gold quality |
| spleen | UBERON:0002106 | 86.85 | gold quality |
| right lobe of liver | UBERON:0001114 | 85.80 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 85.59 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 85.49 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 85.27 | gold quality |
| transverse colon | UBERON:0001157 | 85.02 | gold quality |
| endometrium | UBERON:0001295 | 84.97 | gold quality |
| cortex of kidney | UBERON:0001225 | 84.68 | gold quality |
| skin of abdomen | UBERON:0001416 | 84.62 | gold quality |
| zone of skin | UBERON:0000014 | 84.53 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.48 | gold quality |
| skin of leg | UBERON:0001511 | 84.47 | gold quality |
| small intestine | UBERON:0002108 | 84.06 | gold quality |
| tonsil | UBERON:0002372 | 83.66 | gold quality |
| body of stomach | UBERON:0001161 | 83.60 | gold quality |
| pancreas | UBERON:0001264 | 83.46 | gold quality |
| right ovary | UBERON:0002118 | 83.43 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 83.05 | gold quality |
| right adrenal gland | UBERON:0001233 | 83.02 | gold quality |
| esophagus mucosa | UBERON:0002469 | 82.98 | gold quality |
| left ovary | UBERON:0002119 | 82.95 | gold quality |
| intestine | UBERON:0000160 | 82.94 | gold quality |
| bone marrow | UBERON:0002371 | 82.94 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 82.93 | gold quality |
| vagina | UBERON:0000996 | 82.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.28 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2595.1 | ZNF700 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605530
miRNA regulators (miRDB)
37 targeting ZNF700, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-3912-5P | 99.95 | 66.11 | 925 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-6126 | 99.62 | 68.09 | 996 |
| HSA-MIR-199A-5P | 99.51 | 69.71 | 1107 |
| HSA-MIR-199B-5P | 99.51 | 69.74 | 1098 |
| HSA-MIR-6507-5P | 99.36 | 70.46 | 2524 |
| HSA-MIR-296-3P | 99.21 | 66.56 | 474 |
| HSA-MIR-376A-3P | 99.06 | 69.17 | 1128 |
| HSA-MIR-376B-3P | 99.06 | 69.17 | 1128 |
| HSA-MIR-8066 | 99.05 | 68.66 | 1532 |
| HSA-MIR-4742-3P | 98.73 | 69.82 | 1803 |
| HSA-MIR-548AO-5P | 98.55 | 69.57 | 1362 |
Literature-anchored findings (GeneRIF, showing 1)
- High ZNF700 expression is associated with colorectal cancer. (PMID:25875936)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp961 | ENSMUSG00000052446 |
| rattus_norvegicus | Zfp617 | ENSRNOG00000049856 |
Paralogs (15): ZNF14 (ENSG00000105708), ZNF57 (ENSG00000171970), ZNF791 (ENSG00000173875), ZNF443 (ENSG00000180855), ZNF101 (ENSG00000181896), ZNF563 (ENSG00000188868), ZNF799 (ENSG00000196466), ZNF441 (ENSG00000197044), ZNF433 (ENSG00000197647), ZNF44 (ENSG00000197857), ZNF823 (ENSG00000197933), ZNF442 (ENSG00000198342), ZNF844 (ENSG00000223547), ZNF709 (ENSG00000242852), ZNF878 (ENSG00000257446)
Protein
Protein identifiers
Zinc finger protein 700 — Q9H0M5 (reviewed: Q9H0M5)
All UniProt accessions (3): Q9H0M5, A0A087WVH9, K7EQV7
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001258777, NP_653167* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050758 | Znf_C2H2-type | Family |
Pfam: PF00096, PF01352
UniProt features (24 total): zinc finger region 18, sequence variant 2, chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H0M5-F1 | 72.27 | 0.03 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 42 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN, GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP, GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, chr19p13, HAMAI_APOPTOSIS_VIA_TRAIL_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, FEV_TARGET_GENES, ZFP91_TARGET_GENES, ZNF350_TARGET_GENES, ZNF513_TARGET_GENES, ZNF561_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
376 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF700 | GPBP1L1 | Q9HC44 | 571 |
| ZNF700 | ZNF638 | Q14966 | 474 |
| ZNF700 | LINC03040 | Q8N319 | 411 |
| ZNF700 | ZNF346 | Q9UL40 | 394 |
| ZNF700 | BLTP3B | A0JNW5 | 392 |
| ZNF700 | TADA2A | O75478 | 380 |
| ZNF700 | NT5DC1 | Q5TFE4 | 371 |
| ZNF700 | NXPE4 | Q6UWF7 | 371 |
| ZNF700 | REP15 | Q6BDI9 | 370 |
| ZNF700 | FAM53A | Q6NSI3 | 368 |
| ZNF700 | MAST2 | Q6P0Q8 | 350 |
| ZNF700 | CTDSPL2 | Q05D32 | 325 |
| ZNF700 | TDRP | Q86YL5 | 323 |
| ZNF700 | GALNTL6 | Q49A17 | 311 |
| ZNF700 | SCPEP1 | Q9HB40 | 302 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF700 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | ZNF700 | psi-mi:“MI:0915”(physical association) | 0.370 |
| pyrD | ZNF700 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (1): ZNF700 (Affinity Capture-RNA)
ESM2 similar proteins: A6NDX5, A6NK75, A6NNF4, A6NP11, B4DXR9, B7Z6K7, C9JN71, O43361, O75290, O75373, P0CJ79, P0DKX0, P17019, P17021, P17035, P17039, P35789, Q02386, Q03938, Q08AN1, Q13106, Q15928, Q3ZCX4, Q5R9F0, Q5SXM1, Q68EA5, Q6P9A1, Q6PDB4, Q6ZN06, Q6ZN08, Q6ZNG1, Q76KX8, Q86V71, Q86XN6, Q8IYB9, Q8N4W9, Q8NEP9, Q8TBZ8, Q8TC21, Q8TF32
Diamond homologs: A2RRD8, A6NFI3, A6NM28, A8MUZ8, A8MWA4, B2RUI1, B4DU55, E9Q8G5, O43296, O43361, O75467, O75820, P0CH99, P0CI00, P10078, P16373, P16374, P17021, P17023, P17032, P17097, P17098, P21506, P51786, P52740, Q06732, Q08ER8, Q13106, Q13360, Q13398, Q14592, Q147U1, Q32M78, Q3KQV3, Q3MIS6, Q3SY52, Q571J5, Q5CZA5, Q5HY98, Q5R7I8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
822 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:11948266:T:G | acceptor_gain | 1.0000 |
| 19:11948272:ACAG:A | acceptor_gain | 1.0000 |
| 19:11948273:CA:C | acceptor_loss | 1.0000 |
| 19:11948274:A:AG | acceptor_gain | 1.0000 |
| 19:11948274:AG:A | acceptor_gain | 1.0000 |
| 19:11948275:G:GG | acceptor_gain | 1.0000 |
| 19:11948275:G:GT | acceptor_gain | 1.0000 |
| 19:11948275:GG:G | acceptor_gain | 1.0000 |
| 19:11948275:GGA:G | acceptor_gain | 1.0000 |
| 19:11948275:GGAGT:G | acceptor_gain | 1.0000 |
| 19:11947163:A:AG | acceptor_gain | 0.9900 |
| 19:11947163:ACAT:A | acceptor_gain | 0.9900 |
| 19:11947164:C:G | acceptor_gain | 0.9900 |
| 19:11947165:AT:A | acceptor_gain | 0.9900 |
| 19:11947165:ATGT:A | acceptor_gain | 0.9900 |
| 19:11947166:T:G | acceptor_gain | 0.9900 |
| 19:11947304:ATAGG:A | donor_loss | 0.9900 |
| 19:11947305:TAGGT:T | donor_loss | 0.9900 |
| 19:11947306:AGGT:A | donor_loss | 0.9900 |
| 19:11947307:GGTA:G | donor_loss | 0.9900 |
| 19:11947308:G:C | donor_loss | 0.9900 |
| 19:11947308:G:GG | donor_gain | 0.9900 |
| 19:11947309:T:A | donor_loss | 0.9900 |
| 19:11948265:A:AG | acceptor_gain | 0.9900 |
| 19:11948265:AT:A | acceptor_gain | 0.9900 |
| 19:11948266:T:TA | acceptor_gain | 0.9900 |
| 19:11948272:A:AG | acceptor_gain | 0.9900 |
| 19:11948273:C:G | acceptor_gain | 0.9900 |
| 19:11948273:CAGG:C | acceptor_gain | 0.9900 |
| 19:11948274:AGGA:A | acceptor_gain | 0.9900 |
AlphaMissense
4976 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:11949825:T:C | F601L | 0.994 |
| 19:11949827:C:A | F601L | 0.994 |
| 19:11949827:C:G | F601L | 0.994 |
| 19:11948799:T:C | F259L | 0.992 |
| 19:11948801:T:A | F259L | 0.992 |
| 19:11948801:T:G | F259L | 0.992 |
| 19:11949909:T:C | F629L | 0.992 |
| 19:11949911:C:A | F629L | 0.992 |
| 19:11949911:C:G | F629L | 0.992 |
| 19:11949741:T:C | F573L | 0.991 |
| 19:11949743:C:A | F573L | 0.991 |
| 19:11949743:C:G | F573L | 0.991 |
| 19:11949657:T:C | F545L | 0.986 |
| 19:11949659:C:A | F545L | 0.986 |
| 19:11949659:C:G | F545L | 0.986 |
| 19:11950077:T:C | F685L | 0.985 |
| 19:11950079:C:A | F685L | 0.985 |
| 19:11950079:C:G | F685L | 0.985 |
| 19:11949915:T:C | S631P | 0.984 |
| 19:11949928:T:C | L635P | 0.983 |
| 19:11949993:T:C | F657L | 0.982 |
| 19:11949995:C:A | F657L | 0.982 |
| 19:11949995:C:G | F657L | 0.982 |
| 19:11949387:T:C | F455L | 0.980 |
| 19:11949389:C:A | F455L | 0.980 |
| 19:11949389:C:G | F455L | 0.980 |
| 19:11949747:T:C | S575P | 0.980 |
| 19:11948967:T:C | F315L | 0.979 |
| 19:11948969:T:A | F315L | 0.979 |
| 19:11948969:T:G | F315L | 0.979 |
dbSNP variants (sampled 300 via entrez): RS1000057418 (19:11945987 G>C), RS1000118339 (19:11941121 G>A), RS1000430019 (19:11945837 G>C), RS1000536597 (19:11923777 G>A,C), RS1000541068 (19:11941326 C>A), RS1000969615 (19:11923507 C>A), RS1001063807 (19:11929263 A>G), RS1001164018 (19:11928203 C>G,T), RS1001295190 (19:11926216 T>C,G), RS1001338425 (19:11934988 T>C,G), RS1001362078 (19:11951248 T>C), RS1001530813 (19:11942847 T>C), RS1001549126 (19:11929032 C>T), RS1001666042 (19:11951026 C>T), RS1001690762 (19:11923475 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002337_47 | Amyotrophic lateral sclerosis (sporadic) | 4.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| trichostatin A | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| Temozolomide | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzene | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cisplatin | increases expression | 1 |
| Estradiol | affects expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydrogen Peroxide | affects cotreatment, decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Theophylline | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.